ROVI Announces Capital Reduction and Share Redemption
Company Announcements

ROVI Announces Capital Reduction and Share Redemption

Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.

Laboratorios Farmacéuticos ROVI, S.A. announced a share capital reduction by redeeming treasury shares, aiming to enhance shareholder remuneration. The reduction amounts to 166,823.70 euros through the redemption of 2,780,395 shares, setting the new capital at 3,074,145.72 euros. This action is part of the company’s shareholder remuneration policy and will be followed by delisting the redeemed shares from various Spanish stock exchanges.

For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Spain Auto-Generated NewsdeskROVI Corrects English Communication Error
TipRanks Spain Auto-Generated NewsdeskROVI Retains Control of CDMO Business for Growth
TipRanks Spain Auto-Generated NewsdeskRovi Reports Q3 2024 Treasury Stock Trades
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App